Related references
Note: Only part of the references are listed.Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM
P. Hadji et al.
ANNALS OF ONCOLOGY (2012)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study
J. Sven D. Mieog et al.
LANCET ONCOLOGY (2012)
Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth
Pernille Hojman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Effects of physical activity on cancer prevention
Hye-Kyung Na et al.
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER (2011)
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
Rebecca L. Sedjo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer
Larissa Nekhlyudov et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms
N. Lynn Henry et al.
CANCER (2011)
Effect of Endocrine Therapies on Bone in Breast Cancer Patients
R. J. Santen
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
Claudia Bocca et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Estrogens in rheumatoid arthritis; the immune system and bone
Ulrika Islander et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Paul E. Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
Jun J. Mao et al.
BREAST CANCER RESEARCH (2011)
Immunological Therapies Can Relieve Aromatase Inhibitor-Related Joint Symptoms in Breast Cancer Survivors
Qingyuan Zhang et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
New views on treatment of aromatase inhibitors induced arthralgia
Gr. Xepapadakis et al.
BREAST (2010)
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
Qamar J. Khan et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study
Karine Briot et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?
Omar S. Din et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
IL-17 in obesity and adipogenesis
Mushtaq Ahmed et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Association between nonspecific skeletal pain and vitamin D deficiency
Behzad Heidari et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2010)
Randomized, Blinded, Sham-Controlled Trial of Acupuncture for the Management of Aromatase Inhibitor-Associated Joint Symptoms in Women With Early-Stage Breast Cancer
Katherine D. Crew et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Menopausal arthralgia: Fact or fiction
Malgorzata Magliano
MATURITAS (2010)
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
V. Ziller et al.
ANNALS OF ONCOLOGY (2009)
Aromatase Inhibitor-Related Musculoskeletal Symptoms: Is Preventing Osteoporosis the Key to Eliminating These Symptoms?
Alaa A. Muslimani et al.
CLINICAL BREAST CANCER (2009)
A Comparative Study of Exemestane Versus Anastrozole in Patients with Postmenopausal Breast Cancer with Visceral Metastases
Susana M. Campos et al.
CLINICAL BREAST CANCER (2009)
Aromatase Inhibitor-Induced Carpal Tunnel Syndrome: Results From the ATAC Trial
Ivana Sestak et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
Henning Mouridsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial
Jack Cuzick et al.
LANCET ONCOLOGY (2008)
Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis
Ivana Sestak et al.
LANCET ONCOLOGY (2008)
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
N. Lynn Henry et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer
Katherine D. Crew et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging
Leilani Morales et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Effect of hormone therapy on risk of hip and knee joint replacement in the women's health initiative
Dominic J. Cirillo et al.
ARTHRITIS AND RHEUMATISM (2006)
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17
PE Goss et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial
F Boccardo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The anti-inflammatory effect of exercise
AMW Petersen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
A Howell et al.
LANCET (2005)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
RC Coombes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1
HF d'Elia et al.
ARTHRITIS RESEARCH & THERAPY (2003)
An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole
C Rose et al.
EUROPEAN JOURNAL OF CANCER (2003)
Aromatase in synovial cells from postmenopausal women
JC Le Bail et al.
STEROIDS (2001)
Share Paper
